TIME: Once a day
TIME:
DRUG NAME: Nitro patch
DRUG NAME: Ferrous gluconate
Nitroglycerin patch
Apo-ferrous gluconate
Classification & MOA: Nitrate
Novoferrogluc

converts to nitric oxide (NO) in the body. NO then activates
the enzyme guanylyl cyclase, which converts guanosine

Fertinic
An essential mineral found in hemoglobin, myoglobin, and
many enzymes.

REASON:

Simron
Ferralet
Classification & MOA: Antianemics/iron supplement
triphosphate (GTP) to guanosine 3',5'-monophosphate
(cGMP) in vascular smooth muscle and other tissues.
Fergon
Enters the bloodstream and is transported to (liver, spleen,
bone marrow) where it becomes part of iron stores.
Nitroglycerin transdermal patches are used to prevent
episodes of angina (chest pain) in people who have
coronary artery disease (narrowing of the blood vessels
that supply blood to the heart). Nitroglycerin transdermal
REASON:

Resolution of prevention of iron deficiency anemia.
SAFE DOSE RANGE:

Deficiency 2-3mg/kg/day in day 2-4 divided doses or 60-
patches can only be used to prevent attacks of angina;
100mg elemental iron twice daily. Prophylaxis 60-100mg
they cannot be used to treat an attack of angina once it
elemental iron daily.
has begun. Nitroglycerin is in a class of medications called
PRE-ASSESSMENT:
vasodilators. It works by relaxing the blood vessels so that

Assess nutritional status and dietary history
the heart does not need to work as hard and therefore

Assess bowel function for constipation
does not need as much oxygen.

Monitor hemoglobin, hematocrit and reticulocyte.
SAFE DOSE RANGE:
POST-ASSESSMENT:
PRE-ASSESSMENT:

Assess lab values and bowel functions

Monitor application site for redness and irritation
ONSET: 4 days

Episodes of angina
SIDE EFFECTS:
POST-ASSESSMENT:
ONSET: 2 hours

PEAK:
PEAK: 7-10 days
GI: Nausea, constipation, dark stool, epigastric pain, GI
bleeding, vomiting
SIDE EFFECTS:

Neuro: Dizziness, headache, syncope
Arm, back, or jaw pain.
 blurred vision.
 chest pain or discomfort.
 chest tightness or heaviness.
 confusion.
 dizziness, faintness, or lightheadedness when getting up
suddenly from a lying or sitting position.
 fainting.
 fast or irregular heartbeat.
LAST DOSE (PRN?):

Misc: temporary staining of teeth (liquid preparation)

IS THIS MEDICATION SAFE TO GIVE? •
LAST DOSE (PRN?):
IS THIS MEDICATION SAFE TO GIVE? •
TIME:
TIME:
DRUG NAME:
DRUG NAME:
Classification & MOA:
Classification & MOA:
REASON:
REASON:
SAFE DOSE RANGE:
SAFE DOSE RANGE:
PRE-ASSESSMENT:
PRE-ASSESSMENT:
POST-ASSESSMENT:
POST-ASSESSMENT:
ONSET:
PEAK:
ONSET:
PEAK:
SIDE EFFECTS:
SIDE EFFECTS:
LAST DOSE (PRN?):
LAST DOSE (PRN?):
IS THIS MEDICATION SAFE TO GIVE? •
IS THIS MEDICATION SAFE TO GIVE? •
TIME:
TIME:
DRUG NAME:
DRUG NAME:
Classification & MOA:
Classification & MOA:
REASON:
REASON:
SAFE DOSE RANGE:
SAFE DOSE RANGE:
PRE-ASSESSMENT:
PRE-ASSESSMENT:
POST-ASSESSMENT:
POST-ASSESSMENT:
ONSET:
PEAK:
ONSET:
PEAK:
SIDE EFFECTS:
SIDE EFFECTS:
LAST DOSE (PRN?):
LAST DOSE (PRN?):
IS THIS MEDICATION SAFE TO GIVE? •
IS THIS MEDICATION SAFE TO GIVE? •